Results 31 to 40 of about 36,296 (116)

Human prion diseases and the prion protein - what is the current state of knowledge? [PDF]

Transl Neurosci, 2023
Nafe R, Arendt CT, Hattingen E.
europepmc   +1 more source

'Prion' Diseases

Journal of the Royal College of Physicians of London, 1994
openaire   +2 more sources

1-L Transcription in Prion Diseases. [PDF]

Int J Mol Sci
Nahalka J.
europepmc   +1 more source

Loss of Homeostatic Microglia Signature in Prion Diseases. [PDF]

Cells, 2022
Wang Y, Hartmann K, Thies E, Mohammadi B, Altmeppen H, Sepulveda-Falla D, Glatzel M, Krasemann S.   +7 more
europepmc   +1 more source

Challenges and Revisions in Diagnostic Criteria: Advancing Early Detection of Prion Diseases. [PDF]

Int J Mol Sci
Shimamura MI, Satoh K.
europepmc   +1 more source

Characteristics of Different Types of Prion Diseases - China's Surveillance. [PDF]

China CDC Wkly, 2022
Shi Q, Chen C, Xiao K, Zhou W, Gao C, Gao L, Han J, Wang J, Dong X.   +8 more
europepmc   +1 more source

Downregulation of STAT3 transcription factor reverses synaptotoxic phenotype of reactive astrocytes associated with prion diseases. [PDF]

Acta Neuropathol Commun
Kushwaha R, Molesworth K, Makarava N, Baskakov IV.   +3 more
europepmc   +1 more source

Organoids for modeling prion diseases. [PDF]

Cell Tissue Res, 2023
Walters RO, Haigh CL.
europepmc   +1 more source

Reactive astrocytes in prion diseases: Friend or foe? [PDF]

PLoS Pathog
Makarava N, Kushwaha R, Baskakov IV.
europepmc   +1 more source

Prospective 25-year surveillance of prion diseases in France, 1992 to 2016: a slow waning of epidemics and an increase in observed sporadic forms. [PDF]

Euro Surveill, 2023
Denouel A, Brandel JP, Peckeu-Abboud L, Seilhean D, Bouaziz-Amar E, Quadrio I, Oudart JB, Lehmann S, Bellecave P, Laplanche JL, Haik S.   +10 more
europepmc   +1 more source